Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

References

• Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol. 2012;69(5):576–581.
   PubMedGoogle Scholar
• Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661–674.
   PubMed Web of Science ®Google Scholar
• Luo CL, Li QQ, Chen XP, et al. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. Brain Res. 2013;1502:1–10.
   PubMed Web of Science ®Google Scholar
• Francos-Quijorna I, Santos-Nogueira E, Gronert K, et al. Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury. J Neurosci. 2017;37(48):11731–11743.
   PubMed Web of Science ®Google Scholar
• Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem. 2003;278(44):43807–43817.
   PubMed Web of Science ®Google Scholar
• Perretti M, Leroy X, Bland EJ, et al. Resolution pharmacology : opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci. 2015;36(11):737–755.
   PubMed Web of Science ®Google Scholar
• Perucci LO, Sugimoto MA, Gomes KB, et al. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets. 2017;21(9):879–896.
   PubMed Web of Science ®Google Scholar
• GBD 2015. Neurological disorders collaborator group. global, regional, and national burden of neurological disorders during 1990–2015 : a systematic analysis for the global burden of disease study 2015. Lancet Neurol . 2017;16(11):877–897.
   PubMed Web of Science ®Google Scholar
• Musto AE, Gjorstrup P, Bazan NG. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia. 2011;52(9):1601–1608.
   PubMed Web of Science ®Google Scholar
• Prüss H, Rosche B, Sullivan AB, et al. Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PLoS One. 2013;8(2):e55859.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu M, Hjorth E, et al. Resolution of inflammation is altered in Alzheimer’s disease. Alzheimers Dement. 2015;11(1):40–50.
   PubMed Web of Science ®Google Scholar
• Bisicchia E, Sasso V, Catanzaro G, et al. Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX/FPR2 receptor-regulated MicroRNAs. Mol Neurobiol. 2018;55(8):6894–6905.
   PubMed Web of Science ®Google Scholar
• Duffney PF, Falsetta ML, Rackow AR, et al. Key roles for lipid mediators in the adaptive immune response. J Clin Invest. 2018;128(7):2724–2731.
   PubMed Web of Science ®Google Scholar
• Ortiz-Munoz G, Mallavia B, Bins A, et al. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood. 2014;124(17):2625–2634.
   PubMed Web of Science ®Google Scholar
• Werz O, Gerstmeier J, Libreros S, et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun. 2018;9(1):59.
   PubMedGoogle Scholar
• Zhu M, Wang X, Schultzberg M, et al. Differential regulation of resolution in inflammation induced by amyloid-β42 and lipopolysaccharides in human microglia. J Alzheimers Dis. 2015;43(4):1237–1250.
   PubMed Web of Science ®Google Scholar
• Livne-bar I, Wei J, Liu HH, et al. Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury. J Clin Invest. 2017;127(12):4403–4414.
   PubMed Web of Science ®Google Scholar
• Ke Y, Zebda N, Oskokova O, et al. Anti-inflammatory effects of OxPAPC involve endothelial cell-mediated generation of LXA4. Circ Res. 2017;121(3):244–257.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM. A polarizing question: do M1 and M2 microglia exist. Nat Neurosci. 2016;19(8):987–991.
   PubMed Web of Science ®Google Scholar
• Dong X, Gao J, Zhang CY, et al. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano. 2019;13(2):1272–1283.
   PubMed Web of Science ®Google Scholar
• Hirbec HE, Noristani HN, Perrin FE. Microglia responses in acute and chronic neurological diseases: what microglia-specific transcriptomic studies taught (and did not teach) Us. Front Aging Neurosci. 2017;9:227.
   PubMed Web of Science ®Google Scholar
• Zhu M, Wang X, Hjorth E, et al. Pro-resolving lipid mediators improve neuronal survival and increase Aβ42 phagocytosis. Mol Neurobiol. 2016;53(4):2733–2749.
   PubMed Web of Science ®Google Scholar
• Tahan F, Eke GH, Bicici E, et al. Increased postexercise lipoxin A4 levels in exhaled breath condensate in asthmatic children with exercise-induced bronchoconstriction. J Investig Allergol Clin Immunol. 2016;26(1):19–24.
   PubMed Web of Science ®Google Scholar
• Cacabelos D, Ayala V, Granado-serrano AB, et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016;88:148–160.
   PubMed Web of Science ®Google Scholar
• Yagi S, Fukuda D, Aihara K, et al. n-3 polyunsaturated fatty acids: promising nutrients for preventing cardiovascular disease. J Atheroscler Thromb. 2017;24(10):999–1010.
   PubMed Web of Science ®Google Scholar
• Das UN. Ageing: is there a role for arachidonic acid and other bioactive lipids? A review. J Adv Res. 2018;11:67–79.
   PubMed Web of Science ®Google Scholar
• Das UN. Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. Lipids Health Dis. 2016;15(1):206.
   PubMedGoogle Scholar
• Dyall SC. Long-chain omega-3 fatty acids and the brain : a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52.
   PubMed Web of Science ®Google Scholar
• Ouellet M, Emond V, Chen CT, et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier : an in situ cerebral perfusion study. Neurochem Int. 2009;55(7):476–482.
   PubMed Web of Science ®Google Scholar
• Chen CT, Domenichiello AF, Trépanier MO, et al. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J Lipid Res. 2013;54(9):2410–2422.
   PubMed Web of Science ®Google Scholar
• Demar JC, Ma K, Bell JM, et al. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem. 2004;91(5):1125–1137.
   PubMed Web of Science ®Google Scholar
• Green JT, Liu Z, Bazinet RP. Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet. J Lipid Respid. 2010;51(3):535–543.
   PubMed Web of Science ®Google Scholar
• Dyall SC. Interplay between n‑3 and n‑6 long‑chain polyunsaturated fatty acids and the endocannabinoid system in brain protection and repair. Lipids. 2017;52(11):885–900.
   PubMed Web of Science ®Google Scholar
• Sublette ME, Ellis SP, Geant AL, et al. Meta-analysis of the effects of eicosapentaenoic acid in clinical trials in depression. J Clin Psychiatry. 2011;72(12):1577–1584.
   PubMed Web of Science ®Google Scholar
• Tallima H, EI Ridi R. Arachidonic acid : physiological roles and potential health benefits – A review. J Adv Res. 2017;11:33–41.
   PubMed Web of Science ®Google Scholar
• Levy BD, Clish CB, Schmidt B, et al. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2(7):612–619.
   PubMed Web of Science ®Google Scholar
• Luo M, Jones SM, Phare SM, et al. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J Biol Chem. 2004;279(40):41512–41520.
   PubMed Web of Science ®Google Scholar
• Norris PC, Gosselin D, Reichart D, et al. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci U S A. 2014;111(35):12746–12751.
   PubMed Web of Science ®Google Scholar
• Karp CL, Cooper AM. An oily, sustained counter-regulatory response to TB. J Clin Invest. 2005;115(6):1473–1476.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–215.
   PubMed Web of Science ®Google Scholar
• Ryan A, Godson C. Lipoxins: regulators of resolution. Curr Opin Pharmacol. 2010;10(2):166–172.
   PubMed Web of Science ®Google Scholar
• Qu L, Caterina MJ. Accelerating the reversal of inflammatory pain with NPD1 and its receptor GPR37. J Clin Invest. 2018;128(8):3246–3249.
   PubMed Web of Science ®Google Scholar
• Gobbetti T, Le Faouder P, Bertrand J, et al. Polyunsaturated fatty acid metabolism signature in ischemia differs from reperfusion in mouse intestine. PLoS One. 2013;8(9):e75581.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Treating inflammation and infection in the 21st century : new hints from decoding resolution mediators and mechanisms. Faseb J. 2017;31(4):1273–1288.
   PubMed Web of Science ®Google Scholar
• Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38(1):4–5.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults. Circulation. 2017;135(8):759–771.
   PubMed Web of Science ®Google Scholar
• Ouyang YB. Inflammation and stroke. Neurosci Lett. 2013;548:1–3.
   PubMed Web of Science ®Google Scholar
• Mizuma A, Yenari MA. Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Front Neurol. 2017;8:467.
   PubMed Web of Science ®Google Scholar
• Wu L, Li HH, Wu Q, et al. Lipoxin A4 activates Nrf2 pathway and ameliorates cell damage in cultured cortical astrocytes exposed to oxygen-glucose deprivation/reperfusion insults. J Mol Neurosci. 2015;56(4):848–857.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu ZJ, Miao S, et al. Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2. Neurol Res. 2013;35(9):968–975.
   PubMed Web of Science ®Google Scholar
• Wu L, Miao S, Zou LB, et al. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. J Mol Neurosci. 2012;48(1):185–200.
   PubMed Web of Science ®Google Scholar
• Hawkins KE, Demars KM, Alexander JC, et al. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A(4) analog : protective mechanisms and long-term effects on neurological recovery. Brain Behav. 2017;7(5):e00688.
   PubMed Web of Science ®Google Scholar
• Brancaleone V, Gobbetti T, Cenac N, et al. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood. 2013;122(4):608–617.
   PubMed Web of Science ®Google Scholar
• Leonard MO, Hannan K, Burne MJ, et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J Am Soc Nephrol. 2002;13(6):1657–1662.
   PubMed Web of Science ®Google Scholar
• Smith HK, Gil CD, Oliani SM, et al. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke. Faseb J. 2015;29(5):2161–2171.
   PubMed Web of Science ®Google Scholar
• Prieto P, Rosales-mendoza CE, Terrón V, et al. Activation of autophagy in macrophages by pro-resolving lipid mediators. Autophagy. 2015;11(10):1729–1744.
   PubMed Web of Science ®Google Scholar
• Chiang N, Gronert K, Clish CB, et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest. 1999;104(3):309–316.
   PubMed Web of Science ®Google Scholar
• Mai J, Liu W, Fang YB, et al. The atheroprotective role of lipoxin A(4) prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway. Atherosclerosis. 2018;278:259–268.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Shao L, Hu X, et al. Lipoxin A4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats. Mediators Inflamm. 2013;2013:231351.
   PubMedGoogle Scholar
• Wu Y, Wang YP, Guo P, et al. A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury. J Mol Neurosci. 2012;46(3):483–491.
   PubMed Web of Science ®Google Scholar
• Ye XH, Wu Y, Guo PP, et al. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res. 2010;1323:174–183.
   PubMed Web of Science ®Google Scholar
• Petasis NA, Keledjian R, Sun YP, et al. Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. Bioorganic Med Chem Lett. 2008;18(4):1382–1387.
   PubMed Web of Science ®Google Scholar
• Birnbaum Y, Ye Y, Lin Y, et al. Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat. Circulation. 2006;114(9):929–935.
   PubMed Web of Science ®Google Scholar
• Cai W, Yang T, Liu H, et al. Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair. Prog Neurobiol. 2018;163–164:27–58.
   PubMed Web of Science ®Google Scholar
• Sobrado M, Pereira MP, Ballesteros I, et al. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci. 2009;29(12):3875–3884.
   PubMed Web of Science ®Google Scholar
• Kasuga K, Yang R, Porter TF, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol. 2008;181(12):8677–8687.
   PubMed Web of Science ®Google Scholar
• Zuo G, Zhang D, Mu R, et al. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain. 2018;11(1):9.
   PubMed Web of Science ®Google Scholar
• Li L, Wu Y, Wang Y, et al. Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. J Neuroinflammation. 2014;11:72.
   PubMed Web of Science ®Google Scholar
• Gilbert K, Bernier J, Godbout R, et al. Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. Mar Drugs. 2014;12(11):5396–5407.
   PubMed Web of Science ®Google Scholar
• Xian W, Li T, Li L, et al. Maresin 1 attenuates the inflammatory response and mitochondrial damage in mice with cerebral ischemia/reperfusion in a SIRT1-dependent manner. Brain Res. 2019;1711:83–90.
   PubMed Web of Science ®Google Scholar
• Xian W, Wu Y, Xiong W, et al. The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response. Biochem Biophys Res Commun. 2016;472(1):175–181.
   PubMed Web of Science ®Google Scholar
• Viola JR, Lemnitzer P, Jansen Y, et al. Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ Res. 2016;119(9):1030–1038.
   PubMed Web of Science ®Google Scholar
• Hassan IR, Gronert K. Acute changes in dietary ω-3 and ω-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol. 2009;182(5):3223–3232.
   PubMed Web of Science ®Google Scholar
• Bazan NG, Eady TN, Khoutorova L, et al. Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp Neurol. 2012;236(1):122–130.
   PubMed Web of Science ®Google Scholar
• Eady TN, Belayev L, Khoutorova L, et al. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS One. 2012;7(10):e46151.
   PubMed Web of Science ®Google Scholar
• Belayev L, Mukherjee PK, Balaszczuk V, et al. Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke. Cell Death Differ. 2017;24(6):1091–1099.
   PubMed Web of Science ®Google Scholar
• Muralikumar S, Vetrivel U, Narayanasamy A, et al. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties. Lipids Health Dis. 2017;16(1):17.
   PubMed Web of Science ®Google Scholar
• Taylor CA, Bell JM, Breiding MJ, et al. Traumatic brain injury–related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. MMWR Surveill Summ. 2017;66(9):1–16.
   PubMed Web of Science ®Google Scholar
• Guha A. Management of traumatic brain injury: some current evidence and applications. Postgrad Med J. 2004;80(949):650–653.
   PubMed Web of Science ®Google Scholar
• Mckee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury. Front Immunol. 2016;7:556.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol. 2010;177(4):1576–1591.
   PubMed Web of Science ®Google Scholar
• Shearer GC, Walker RE. An overview of the biologic effects of omega-6 oxylipins in humans. Prostaglandins Leukot Essent Fat Acids. 2018;137:26–38.
   PubMed Web of Science ®Google Scholar
• Baratz R, Tweedie D, Wang JY, et al. Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation. 2015;12:45.
   PubMed Web of Science ®Google Scholar
• Harriso JL, Rowe RK, Ellis TW, et al. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain Behav Immun. 2015;47:131–140.
   PubMed Web of Science ®Google Scholar
• Badhiwala JH, Wilson JR, Fehlings MG. Global burden of traumatic brain and spinal cord injury. Lancet Neurol. 2019;18(1):24–25.
   PubMed Web of Science ®Google Scholar
• McDonald JW, Sadowsky C. Spinal cord injury. Lancet. 2002;359(9304):417–425.
   PubMed Web of Science ®Google Scholar
• Anwar MA, Al Shehabi TS, Eid AH. Inflammogenesis of secondary spinal cord injury. Front Cell Neurosci. 2016;10:98.
   PubMed Web of Science ®Google Scholar
• Sun X, Jones ZB, Chen XM, et al. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016;13(1):260.
   PubMedGoogle Scholar
• Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209(2):378–388.
   PubMed Web of Science ®Google Scholar
• Gensel JC, Donnelly DJ, Popovich PG. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets. 2011;15(4):505–518.
   PubMed Web of Science ®Google Scholar
• Rust R, Kaiser J. Insights into the dual role of inflammation after spinal cord injury. J Neurosci. 2017;37(18):4658–4660.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
   PubMed Web of Science ®Google Scholar
• Lu T, Wu X, Wei N, et al. Lipoxin A4 protects against spinal cord injury via regulating Akt/nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 signaling. Biomed Pharmacother. 2018;97:905–910.
   PubMed Web of Science ®Google Scholar
• Han X, Yao W, Liu Z, et al. Lipoxin A4 preconditioning attenuates intestinal ischemia reperfusion injury through Keap1/Nrf2 pathway in a lipoxin A4 receptor independent manner. Oxid Med Cell Longev. 2016;2016:9303606.
   PubMed Web of Science ®Google Scholar
• Liu ZQ, Zhang HB, Wang J, et al. Lipoxin A4 ameliorates ischemia/reperfusion induced spinal cord injury in rabbit model. Int J Clin Exp Med. 2015;8(8):12826–12833.
   PubMed Web of Science ®Google Scholar
• Huaman MA, Fiske CT, Jones TF, et al. Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study. Epidemiol Infect. 2015;143(5):951–959.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Dalli J, Karamnov S, et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. Faseb J. 2012;26(4):1755–1765.
   PubMed Web of Science ®Google Scholar
• Zhao P, Waxman SG, Hains BC. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J Neurosci. 2007;27(33):8893–8902.
   PubMed Web of Science ®Google Scholar
• Huie JR, Baumbauer KM, Lee KH, et al. Glial tumor necrosis factor alpha (TNFα) generates metaplastic inhibition of spinal learning. PLoS One. 2012;7(6):e39751.
   PubMed Web of Science ®Google Scholar
• Martini AC, Berta T, Forner S, et al. Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. J Neuroinflammation. 2016;13(1):75.
   PubMedGoogle Scholar
• Kanda H, Kobayashi K, Yamanaka H, et al. Microglial TNFα induces COX2 and PGI2 synthase expression in spinal endothelial cells during neuropathic pain. eNeuro. 2017;4:2.
   Web of Science ®Google Scholar
• Martini AC, Forner S, Bento AF, et al. Neuroprotective effects of lipoxin A4 in central nervous system pathologies. Biomed Res Int. 2014;2014:316204.
   PubMedGoogle Scholar
• Svensson CI, Zattoni M, Serhan CN. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med. 2007;204(2):245–252.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Li Q, Liu SB, et al. Aspirin-triggered lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in rats. Neuroscience. 2014;273:65–78.
   PubMed Web of Science ®Google Scholar
• Zhang L, Terrando N, Xu ZZ, et al. Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice. Front Pharmacol. 2018;9:412.
   PubMed Web of Science ®Google Scholar
• Xu ZZ, Berta T, Ji RR. Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. J Neuroimmune Pharmacol. 2013;8(1):37–41.
   PubMed Web of Science ®Google Scholar
• Francos-Quijorna I, Amo-Aparicio J, Martinez-Muriana A, et al. 4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury. Glia. 2016;64(12):2079–2092.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Xu Y, Pearse DD. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation. 2016;13:9.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Chen X, Wang W, et al. Electroacupuncture pretreatment attenuates spinal cord ischemia-reperfusion injury via inhibition of high-mobility group box 1 production in a LXA(4) receptor-dependent manner. Brain Res. 2017;1659:113–120.
   PubMed Web of Science ®Google Scholar
• Saiwai H, Kumamaru H, Ohkawa Y, et al. Ly6C + Ly6G − Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury. J Neurochem. 2013;125(1):74–88.
   PubMed Web of Science ®Google Scholar
• Tosto G, Reitz C. Genome-wide association studies in Alzheimer’s disease: A review. Curr Neurol Neurosci Rep. 2013;13(10):381.
   PubMed Web of Science ®Google Scholar
• Morris MC, Gilliam EA, Li L. Innate immune programing by endotoxin and its pathological consequences. Front Immunol. 2015;5:680.
   PubMed Web of Science ®Google Scholar
• Lee JY, Han SH, Park MH, et al. Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease. Nat Commun. 2018;9(1):1479.
   PubMedGoogle Scholar
• Lukiwi WJ, Cui JG, Marcheselli VL, et al. A role for docosahexaenoic acid– derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005;115(10):2774–2783.
   PubMed Web of Science ®Google Scholar
• Dunn HC, Ager RR, Baglietto-Vargas D, et al. Restoration of lipoxin A4 signaling reduces alzheimer’s disease-like pathology in the 3xTg-AD mouse model. J Alzheimers Dis. 2015;43(3):893–903.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Calon F, Julien C, et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer’s disease models. PLoS One. 2011;6(1):e15816.
   PubMed Web of Science ®Google Scholar
• Kantarci A, Aytan N, Palaska I, et al. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer’s disease. Exp Neurol. 2018;300:111–120.
   PubMed Web of Science ®Google Scholar
• Hopperton KE, Trépanier MO, James NCE, et al. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer’s disease. Brain Behav Immun. 2018;69:74–90.
   PubMed Web of Science ®Google Scholar
• Wang X, Hjorth E, Vedin I, et al. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res. 2015;56(3):674–681.
   PubMed Web of Science ®Google Scholar
• Tiffany HL, Lavigne MC, Cui YH, et al. Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem. 2001;276(26):23645–23652.
   PubMed Web of Science ®Google Scholar
• Medeiros R, Kitazawa M, Passos GF, et al. Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces alzheimer disease-like pathology in mice. Am J Pathol. 2013;182(5):1780–1789.
   PubMed Web of Science ®Google Scholar
• Duda P, Wiśniewski J, Wójtowicz T, et al. Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging. Expert Opin Ther Targets. 2018;22(10):833–848.
   PubMed Web of Science ®Google Scholar
• Pamplona FA, Ferreira J, Menezes de Lima OJ, et al. Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci U S A. 2012;109(51):21134–21139.
   PubMed Web of Science ®Google Scholar
• Trovato A, Siracusa R, Di Paola R, et al. Redox modulation of cellular stress response and lipoxin A4 expression by coriolus versicolor in rat brain: relevance to Alzheimer’s disease pathogenesis. Neurotoxicology. 2016;53:350–358.
   PubMed Web of Science ®Google Scholar
• Mizwicki MT, Liu G, Fiala M, et al. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer’s disease patients. J Alzheimers Dis. 2013;34(1):155–170.
   PubMed Web of Science ®Google Scholar
• Marcello E, Borroni B, Pelucchi S, et al. ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer’s disease. Expert Opin Ther Targets. 2017;21(11):1017–1026.
   PubMed Web of Science ®Google Scholar
• Scalfari A, Knappertz V, Cutter G, et al. Mortality in patients with multiple sclerosis. Neurology. 2013;81(2):184–192.
   PubMed Web of Science ®Google Scholar
• Hernández-Pedro NY, Espinosa-Ramirez G, De La Cruz VP, et al. Initial immunopathogenesis of multiple sclerosis: innate immune response. Clin Dev Immunol. 2013;2013:413465.
   PubMedGoogle Scholar
• Das UN. Is multiple sclerosis a proresolution deficiency disorder? Nutrition. 2012;28(10):951–958.
   PubMed Web of Science ®Google Scholar
• Choi BY, Jung JW, Suh SW. The emerging role of zinc in the pathogenesis of multiple sclerosis. Int J Mol Sci. 2017;18:10.
   Web of Science ®Google Scholar
• Maekawa T, Hosur K, Abe T, et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-CEBPβ pathway. Nat Commun. 2015;6:8272.
   PubMed Web of Science ®Google Scholar
• Emerson MR, Levine SM. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res. 2004;1021(1):140–145.
   PubMed Web of Science ®Google Scholar
• Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation. 2018;15(1):144.
   PubMedGoogle Scholar
• Roseti C, van Vliet EA, Cifelli P, et al. GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis. Neurobiol Dis. 2015;82:311–320.
   PubMed Web of Science ®Google Scholar
• Abd-Elghafour BA, El-Sayed NM, Ahmed AA, et al. Aspirin and(or) omega-3 polyunsaturated fatty acids protects against cortico- hippocampal neurodegeneration and downregulates lipoxin A4 production and formyl peptide receptor-like 1 expression in pentylenetetrazole-kindled rats. Can J Physiol Pharmacol. 2017;95(4):340–348.
   PubMed Web of Science ®Google Scholar
• Bazan NG, Calandria JM, Gordon WC. Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system. Nestle Nutr Inst Workshop Ser. 2013;77:121–131.
   PubMedGoogle Scholar
• Reda DM, Abd-el-fatah NK, Tel-S O, et al. Fish oil intake and seizure control in children with medically resistant epilepsy. N Am J Med Sci. 2015;7(7):317–321.
   PubMed Web of Science ®Google Scholar
• Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 2011;44(2):216–222.
   PubMed Web of Science ®Google Scholar
• Musto AE, Walker CP, Petasis NA, et al. Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin D1. PLoS One. 2015;10(1):e0116543.
   PubMed Web of Science ®Google Scholar
• Frigerio F, Pasqualini G, Craparotta I, et al. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain. 2018;141(11):3130–3143.
   PubMedGoogle Scholar
• Taylor JP, Brown RHJ, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197–206.
   PubMed Web of Science ®Google Scholar
• Liu G, Fiala M, Mizwicki MT, et al. Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1. Am J Neurodegener Dis. 2012;1(1):60–74.
   PubMedGoogle Scholar
• Appolinário PP, Medinas DB, Chaves-filho AB, et al. Oligomerization of Cu, Zn-superoxide dismutase (SOD1) by docosahexaenoic acid and its hydroperoxides In Vitro : aggregation dependence on fatty acid unsaturation and thiols. PLoS One. 2015;10(4):e0125146.
   PubMed Web of Science ®Google Scholar
• Arima H, Omura T, Hayasaka T, et al. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Neuroscience. 2015;297:127–136.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11(3):246–254.
   PubMed Web of Science ®Google Scholar
• Kessler RA, Mealy MA, Levy M. Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic. Curr Treat Options Neurol. 2016;18(1):2.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiao W, Lin M, et al. Resolution of inflammation in neuromyelitis optica spectrum disorders. Mult Scler Relat Dis. 2019;27:34–41.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Hlusicka J, Nurieva O, et al. Neuroinflammation markers and methyl alcohol induced toxic brain damage. Toxicol Lett. 2018;298:60–69.
   PubMed Web of Science ®Google Scholar
• Pascoal LB, Bombassaro B, Ramalho AF, et al. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation. 2017;14(1):5.
   PubMedGoogle Scholar
• Ramon S, Baker SF, Sahler JM, et al. The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus:a new class of adjuvant ? J Immunol. 2014;193(12):6031–6040.
   PubMed Web of Science ®Google Scholar
• Croasdell A, Lacy SH, Thatcher TH, et al. Resolvin D1 dampens pulmonary inflammation and promotes clearance of nontypeable haemophilus influenzae. J Immunol. 2016;196(6):2742–2752.
   PubMed Web of Science ®Google Scholar
• Chiang N, Fredman G, Bäckhed F, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484(7395):524–528.
   PubMed Web of Science ®Google Scholar
• Petri MH, Laguna-Fernandez A, Arnardottir H, et al. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E -/- mice. Br J Pharmacol. 2017;174(22):4043–4054.
   PubMed Web of Science ®Google Scholar
• Ueda T, Fukunaga K, Seki H, et al. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*. Crit Care Med. 2014;42(4):e288–95.
   PubMed Web of Science ®Google Scholar
• Poupot R, Bergozza D, Fruchon S. Nanoparticle-based strategies to treat neuro-inflammation. Materials (Basel). 2018;11:2.
   Web of Science ®Google Scholar
• Reis MB, Pereira PAT, Caetano GF, et al. Lipoxin A 4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers. PLoS ONE. 2017;12(7):e0182381.
   PubMed Web of Science ®Google Scholar
• Norling LV, Spite M, Yang R, et al. Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J Immunol. 2011;186(10):5543–5547.
   PubMed Web of Science ®Google Scholar
• Arnardottir HH, Dalli J, Colas RA, et al. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nanoproresolving medicines. J Immunol. 2014;193(8):4235–4244.
   PubMed Web of Science ®Google Scholar
• Mulik RS, Bing C, Ladouceur-Wodzak M, et al. Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound. Biomaterials. 2016;83:257–268.
   PubMed Web of Science ®Google Scholar
• Cholkar K, Trinh HM, Vadlapudi AD, et al. Interaction studies of resolvin E1 analog (RX-10045) with efflux transporters. J Ocul Pharmacol Ther. 2015;31(4):248–255.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Fredman G, Subramanian M, et al. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc Natl Acad Sci U S A. 2013;110(16):6506–6511.
   PubMed Web of Science ®Google Scholar
• Leoni G, Neumann PA, Kamaly N, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 2015;125(3):1215–1227.
   PubMed Web of Science ®Google Scholar
• Bright JM, Sullivan PS, Melton SL, et al. The effects of n-3 fatty acid supplementation on bleeding time, plasma fatty acid composition, and in vitro platelet aggregation in cats. J Vet Intern Med. 1994;8(4):247–252.
   PubMed Web of Science ®Google Scholar
• Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985;312(19):1217–1224.
   PubMed Web of Science ®Google Scholar
• Silva CAM, Belisle JT. Host lipid mediators in leprosy : the hypothesized contributions to pathogenesis. Front Immunol. 2018;9:134.
   PubMed Web of Science ®Google Scholar
• Bafica A, Scanga CA, Serhan C, et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase–dependent lipoxin production. J Clin Invest. 2005;115(6):1601–1606.
   PubMed Web of Science ®Google Scholar
• Tobin DM, Roca FJ, Oh SF, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012;148(3):434–446.
   PubMed Web of Science ®Google Scholar
• Chang CH, Tseng PT, Chen NY, et al. Safety and tolerability of prescription omega-3 fatty acids: a systematic review and meta-analysis of randomized controlled trials. Prostaglandins Leukot Essent Fat Acids. 2018;129:1–12.
   PubMed Web of Science ®Google Scholar
• Hall WL. Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutr Res Rev. 2009;22(1):18–38.
   PubMed Web of Science ®Google Scholar
• Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med. 2017;58:114–129.
   PubMed Web of Science ®Google Scholar
• Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40(3):315–327.
   PubMed Web of Science ®Google Scholar
• Garabuczi É, Sarang Z, Szondy Z. Glucocorticoids enhance prolonged clearance of apoptotic cells by upregulating liver X receptor, peroxisome proliferator-activated receptor- δ and UCP2. Biochim Biophys Acta. 2015;1853(3):573–582.
   PubMed Web of Science ®Google Scholar
• Ruhnau J, Schulze J, Dressel A, et al. Thrombosis,neuroinflammation,and poststroke infection : the multifaceted role of neutrophils in stroke. J Immunol Res. 2017;2017:5140679.
   PubMed Web of Science ®Google Scholar
• Anrather J, Iadecola C. Inflammation and stroke : an overview. Neurotherapeutics. 2016;13(4):661–670.
   PubMed Web of Science ®Google Scholar
• Garcia-Arguello LY, O’Horo JC, Farrell A, et al. Infections in the spinal cord-injured population : a systematic review. Spinal Cord. 2017;55(6):526–534.
   PubMed Web of Science ®Google Scholar
• Fullerton JN, Gilroy DW. Resolution of inflammation : a new therapeutic frontier. Nat Rev Drug Discov. 2016;15(8):551–567.
   PubMed Web of Science ®Google Scholar
• Satish M, Agrawal DK. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases. Expert Rev Cardiovasc Ther. 2019;17(3):177–184.
   PubMed Web of Science ®Google Scholar
• Harrison JL, Rowe RK, Lifshitz J. Lipid mediators of inflammation in neurological injury : shifting the balance toward resolution. Neural Regen Res. 2016;11(1):77–78.
   PubMed Web of Science ®Google Scholar
• Zhu M, Wang X, Sun L, et al. Can inflammation be resolved in Alzheimer’s disease? Ther Adv Neurol Disord. 2018;11:1756286418791107.
   Web of Science ®Google Scholar
• Chiang N, Barnaeva E, Hu X, et al. Identification of chemotype agonists for human resolvin D1 Receptor DRV1 with pro-resolving functions. Cell Chem Biol. 2019;26(2):244–254.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Rong J. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases. Expert Opin Ther Targets. 2019;23(5):423–436.
   PubMed Web of Science ®Google Scholar
• Sugimoto MA, Vago JP, Teixeira MM, et al. Annexin A1 and the resolution of inflammation : modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res. 2016;2016:8239258.
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Serada S, Morimoto A, et al. Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers. Expert Opin Ther Targets. 2014;18(4):403–414.
   PubMed Web of Science ®Google Scholar
• Feng J, Zhang C, Lischinsky JE, et al. A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine. Neuron. 2019;102(4):745–761.e8.
   PubMed Web of Science ®Google Scholar